PharmaBoardroom

Interview with Brian Daniel, CEO & Country Manager, Pfizer…

Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have…

Interview with Vicki St Quintin, COO, PIASA. Pharmaceutical…

South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1…

Interview with Michael Flemming, Chief Executive Officer, Life…

Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last…

Interview with Ann-Marie Hosang-Archer, Managing Director SA…

You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South…

Interview with Joong Keun Cha, President & CEO, Yuhan

Yuhan is one of the largest and fastest growing pharmaceutical companies in South Korea, with a long history in the sector. In your view, what are the…

Interview with WonJung Choi, President, Dream CIS

South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea's…

Interview with Zdeněk Zahradník, General Manager, Teva Czech…

Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical…

Interview with Richard de Chastelain, Country Division Head,…

Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare…

Interview with Hoon Han, President, Histostem

After spending a large part of your career as a university professor, what drove you to create your own company, Histostem, in 2000? In 1993, I…

Interview with Laura Engelbrecht Joubert, General Manager –…

Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations…

Stephen Saad, Group Chief Executive, Aspen

The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years…

Interview with Patrick Godard, Chief Executive Officer, Amayeza…

Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It…

Tagged with